The appearance of troglitazone, a potent antidiabetic agent, marked a notable chapter in the treatment of type 2 diabetes. However, its discontinuation from the market due to serious hepatotoxicity spurred broad https://keziaunzq511185.pointblog.net/troglitazone-and-related-tzds-a-comparative-overview-91874169